Health & Pharm General

Queensland Bauxite Ltd (ASX:QBL) Letter Sent to Option Holders Regarding Expiry of Options

🕔7/21/2017 8:31:34 AM

This is a reminder notice that your options to subscribe for ordinary fully paid shares in Queensland Bauxite Limited (ASX:QBL) will expire at 5:00pm Australian Western Standard Time on 31 July 2017.

Read Full Article

Zoono Group Ltd (ASX:ZNO) Woolworths (ASX:WOW) to Stock Stayzon Hand Sanitiser

🕔7/19/2017 2:08:22 PM

Zoono Group Limited (ASX:ZNO) is pleased to announce that, via its distributor Stayzon, the supermarket giant, Woolworths Limited (ASX:WOW), will stock Zoono's Hand Sanitiser & Protectant. The Stayzon branded hand sanitiser products will be available for sale from early August 2017.

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article

Bluechiip Ltd (ASX:BCT) Change of Share Registry

🕔7/17/2017 8:20:06 AM

Bluechiip Limited (ASX:BCT) advises that as of Monday, 17 July 2017, the Company has changed its provider for shareholder registry services from BoardRoom Pty Limited to Automic Registry Services.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Extension of Share Purchase Plan

🕔7/14/2017 11:26:52 AM

Oventus Medical Limited (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. Oventus wishes to advise that the closing date for the SPP will be extended from Wednesday 19 July 2017 to Monday 31 July 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Receives FDA Clearance for the O2Vent W

🕔7/12/2017 9:29:37 AM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.

Read Full Article

Regeneus Ltd (ASX:RGS) US Patent Allowed for Sygenus Secretions Technology for Acne

🕔7/10/2017 9:26:34 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the United States Patent Office has issued a notice of allowance for a patent covering the composition, manufacture and use of the secretion stem cell technology platform, known as Sygenus, to treat acne. We recently informed the market of the new name for the secretions platform in our Q2 2017 Update.

Read Full Article